Congressman Morgan Griffith, Chairman of the Subcommittee on Health, led a hearing titled "Policies to Protect Our Communities from Illicit Drug Threats" in Washington, D.C., according to a Mar. 26 announcement. The hearing focused on legislative efforts aimed at curbing the impact of dangerous substances such as xylazine and fentanyl.
The issue is significant as communities across the country face increasing challenges related to illicit drug use and overdose deaths. The House Energy and Commerce Committee, which oversees health care among other areas, has historically played a role in shaping legislation related to these concerns according to its official website.
Griffith said, “I hear countless stories across my district of individuals taking illicit drugs and mixing them with drugs we discussed today, like xylazine and fentanyl. While some of these bills may need further work, it is critical that we continue to look for ways to restrict access to lethal and dangerous substances in order to protect American lives, strengthen public safety, and prevent further harm to families and communities nationwide.”
Congressman John Joyce voiced support for H.R. 1266, the Combating Illicit Xylazine Act: “Under the leadership of President Trump, we have finally closed our Southern Border and made all Americans safer by that action. However, we all recognize there is more work to be done... I’d like to really publicly express my strong support for H.R. 1266... which would permanently schedule this substance while providing the necessary safe harbor for its continued legitimate veterinary use.”
Congressman Neal Dunn addressed rising overdose deaths: “You know, in 2025, the CDC reported an estimated 72,000 deaths from overdose... Fentanyl alone accounts for an estimated 45,000 deaths in 2025... This is not just a domestic public health problem. This is a national security issue...”
Congresswoman Mariannette Miller-Meeks highlighted her bill aiming at opioid alternatives: “Increasing access to opioid alternatives not only can reduce the cost of medical care but can also improve patient outcomes... My bill... is written to ensure more patients get this approach and reduce the risk of addiction from prescription opioids.”
The House Energy and Commerce Committee stands as one of the oldest standing committees in Congress according to its official website, having influenced policy on energy innovation and pharmaceutical pricing over time as reported by its official website. Its origins date back as far as 1795 when it was first formed as the Committee on Commerce and Manufactures according to its official website.
As lawmakers continue their discussions around new legislation targeting synthetic opioids and other dangerous substances mixed into street drugs—such as those described during this hearing—the committee's actions could shape future responses at both state and national levels.
